PharmaPhD
PharmaPhD is a biotechnology company founded in 2012, focusing on developing patented innovations in local anesthetics, periodontal methods, and nanoparticle drug formulations. Their core business revolves around research and development in niche markets with significant unmet needs, particularly in periodontal disease and pain management. The company leverages specialized knowledge in nanoparticle formulation technology and holds multiple patents from the USPTO. They have developed AI software for periodontal diagnosis and planning, versatile anesthetic injection systems with mixing carpule technology, and novel periodontal devices aimed at reshaping localized periodontal therapy. PharmaPhD has achieved FDA clearance for a standalone medical device and anticipates FDA approval for three finished drug products in 2025. Their business model appears to be a combination of product development, patent licensing, and potentially sales of their finished products and software.
PharmaPhD
PharmaPhD is a biotechnology company founded in 2012, focusing on developing patented innovations in local anesthetics, periodontal methods, and nanoparticle drug formulations. Their core business revolves around research and development in niche markets with significant unmet needs, particularly in periodontal disease and pain management. The company leverages specialized knowledge in nanoparticle formulation technology and holds multiple patents from the USPTO. They have developed AI software for periodontal diagnosis and planning, versatile anesthetic injection systems with mixing carpule technology, and novel periodontal devices aimed at reshaping localized periodontal therapy. PharmaPhD has achieved FDA clearance for a standalone medical device and anticipates FDA approval for three finished drug products in 2025. Their business model appears to be a combination of product development, patent licensing, and potentially sales of their finished products and software.